NCT00219219 Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases Status COMPLETED Phase PHASE4
NCT00219193 A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients Status COMPLETED Phase PHASE3
NCT00219180 Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure Status COMPLETED Phase PHASE3
NCT00219167 A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure Status COMPLETED Phase PHASE3
NCT00219154 A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine Status COMPLETED Phase PHASE3
NCT00219128 A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. Status COMPLETED Phase PHASE3
NCT00219115 A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg Status COMPLETED Phase PHASE3
NCT00219102 A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients Status COMPLETED Phase PHASE3
NCT00219089 A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients. Status COMPLETED Phase PHASE3
NCT00219076 A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients Status COMPLETED Phase PHASE3
NCT00219063 A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. Status COMPLETED Phase PHASE3
NCT00219050 A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension Status COMPLETED Phase PHASE3
NCT00219037 Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00219024 Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension. Status COMPLETED Phase PHASE3
NCT00219011 "ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure Status COMPLETED Phase PHASE3
NCT00215943 Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) Status TERMINATED Phase PHASE3
NCT00210184 Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer Status COMPLETED Phase PHASE2
NCT00210119 Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response Status TERMINATED Phase PHASE2
NCT00209079 Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma Status TERMINATED Phase PHASE2
NCT00208273 Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer Status COMPLETED Phase PHASE2